Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 43 publications
Survival and Renal Recovery in Newly Diagnosed Multiple Myeloma Patients Presenting With Dialysis-Requiring Severe Renal Impairment.
Journal: European journal of haematology
Published: October 09, 2025
The Impact of CD34+ Cell Collection Yields for Autologous Transplant on Survival Outcomes in Multiple Myeloma.
Journal: Clinical lymphoma, myeloma & leukemia
Published: April 03, 2023
Single-cell profiling of multiple myeloma reveals molecular response to FGFR3 inhibitor despite clinical progression.
Journal: Cold Spring Harbor molecular case studies
Published: September 30, 2022
Post Salvage Therapy Autologous Transplant for Relapsed Myeloma, Ongoing Relevance within Modern Treatment Paradigms?
Journal: Clinical lymphoma, myeloma & leukemia
Published: September 01, 2022
Correction to "Design, Synthesis, and Characterization of 4-Aminoquinazolines as Potent Inhibitors of the G Protein-Coupled Receptor Kinase 6 (GRK6) for the Treatment of Multiple Myeloma".
Journal: Journal of medicinal chemistry
Published: December 28, 2021
Fixed duration vs. prolonged duration treatment after first line therapy in patients with systemic light chain amyloidosis.
Journal: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis
Published: September 14, 2021
Kinetics of response to first- and second-line therapies in multiple myeloma: Assessment by both M-spikes and light chains.
Journal: European journal of haematology
Published: July 28, 2021
Design, Synthesis, and Characterization of 4-Aminoquinazolines as Potent Inhibitors of the G Protein-Coupled Receptor Kinase 6 (GRK6) for the Treatment of Multiple Myeloma.
Journal: Journal of medicinal chemistry
Published: July 22, 2021
sciCNV: high-throughput paired profiling of transcriptomes and DNA copy number variations at single-cell resolution.
Journal: Briefings in bioinformatics
Published: July 08, 2021
A descriptive cost-analysis of MYX.1/MCRN003, a phase 2 clinical trial evaluating high-dose weekly carfilzomib, cyclophosphamide, and dexamethasone in relapsed and refractory multiple myeloma.
Journal: European journal of haematology
Published: March 23, 2021
Symptomatic BK Virus Disease in Patients With Heavily Pretreated Multiple Myeloma.
Journal: Clinical lymphoma, myeloma & leukemia
Published: November 17, 2020
Last Updated: 09/26/2026